Europe Negative Pressure Wound Therapy Market - Focused Insights 2023-2028

Europe Negative Pressure Wound Therapy Market - Focused Insights 2023-2028
REPORT OVERVIEW

This report provides an in-depth analysis of the complete Europe NPWT market. Exhaustive information regarding the shift towards adopting innovative products in Europe. One of the major reasons for the lower adoption of NPWT products in the market is the need for reimbursement in some European countries. Constant product launches in the market from key vendors to gain market share is included. A constant increase in the number of target population is driving the market.

The economic burden of a wound per year in Europe is approximately $6500-$8000. Healthcare bodies are introducing multiple strategies and regulations to reduce the economic burden and to increase the adoption of advanced products for faster recovery and reducing re-admissions. The awareness among wound care specialists is increasing. Specialty wound care hospitals collaborate with large hospitals providing better care to the patients.

MARKET DEFINITION

NPWT is a wound care treatment that can be used for wounds on all parts of the body. It involves the application of negative pressure to the wound, which aids in reducing edema by removing excess fluid. Additionally, this therapy facilitates wound compression, thereby promoting the growth of new healthy tissue and the formation of blood vessels.

KEY HIGHLIGHTS:

The number of diabetics, obese patients, and patients with co-morbidities is increasing constantly in Europe. This leads to an increase in pressure ulcers and prolonged healing of wounds. The increasing target population will drive the demand for NPWT in the European market.

Conventional NPWT market has a higher contribution as it has a higher adoption rate among healthcare professionals. The hospitals and wound care clinics are major end-users of NPWT products and constitute for major market share

Improper reimbursement for the NPWT is one of the major reasons for the slower adoption of products in developed markets like Italy, France, and the UK

The awareness among people of wound care is very low. People prefer conventional treatments and choose not to go for advanced treatments. This is a major limitation for the adoption of NPWT treatments in EuropeThere is a constant increase in the number of surgeries performed in European countries. Increasing access to healthcare settings is increasing the number of elective surgeries. This will increase the demand for NPWT products in the market.VENDORS

Key Vendors

Smith+Nephew

3M

Convatech

Other Prominent Vendors

Alleva medical

Cardinal Health

Carilex

Deroyal

Genadyne

Haromed

Hartmann

Medela

Molnlycke

Lohmann & Rausch

Talley Group

Traiage Meditech

REPORT HIGHLIGHTS

SEGMENTATION & FORECASTProductConventional NPWT

Single Use NPWTEnd-UserHospitals

Wound Care Clinics

ASCs

OthersWound TypeChronic Wound

Acute WoundCountry AnalysisGermany

France

UK

Italy

Spain

MARKET STRUCTUREMarket DynamicsCompetitive Landscape Key VendorsOther Prominent VendorsStrategic RecommendationsQuantitative SummaryAbbreviationsAPPENDIXResearch MethodologyAbbreviationsAbout Arizton